UNITED HYDROGEN GLOBAL INC.

EFFECT effective

424B3 priced

157,568,135 shares · Gross proceeds $1,500,000,000

The current filing for United Hydrogen Global Inc. outlines the legal and financial details surrounding the Business Combination, including the validity of shares, expert auditors, and shareholder communication protocols. It highlights the company's transition to a foreign private issuer, changes in proxy solicitation, and financial risks related to PRC legal enforcement and liquidity. The document emphasizes the role of Cayman Islands counsel and independent auditors, along with the company's reliance on external financing for growth.

EFFECT effective

F-4/A amended

6,900,000 shares

F-4/A amended

6,900,000 shares

F-4/A amended

United Hydrogen Global Inc. (Pubco) is completing a business combination with Aimei Health Technology Co., Ltd., resulting in United Hydrogen becoming a wholly owned subsidiary of Pubco. The transaction involves a $1.5B merger consideration paid in newly issued Class A and Class B shares of Pubco. Shareholders of United Hydrogen will receive Pubco shares based on an exchange ratio, while Aimei Health shareholders will convert their securities into Pubco shares. The dual-class voting structure grants Class B shareholders (controlled by Xia Ma) ten votes per share versus one for Class A, concentrating voting power. The filing includes details on share conversions, redemption terms, and ownership percentages post-transaction.

F-4/A amended

United Hydrogen Global Inc. filed an F-4/A registration statement for a business combination involving a merger with Aimei Health Technology Co., Ltd. The transaction involves the exchange of United Hydrogen shares for Pubco (United Hydrogen Global Inc.) Class A and Class B Ordinary Shares, with a dual-class voting structure. The filing outlines the conversion of shares, voting rights, and ownership percentages post-merger, emphasizing the concentration of voting power under the Class B shares controlled by Xia Ma via Michael&Jason Limited.

F-4/A amended

Gross proceeds $1,500,000,000

United Hydrogen Global Inc. filed an F-4/A registration statement to register securities issued in connection with a business combination involving Aimei Health Technology Co., Ltd. The transaction involves merging United Hydrogen Group Inc. with two merger subsidiaries, resulting in United Hydrogen becoming a wholly owned subsidiary of Pubco. The deal includes a $1.5 billion aggregate merger consideration paid in newly issued Class A and Class B shares of Pubco, with a dual-class voting structure favoring Class B shares. The filing outlines the conversion of shares, voting rights, and the concentration of control by Xia Ma through Michael&Jason Limited.

F-4/A amended

Gross proceeds $1,500,000,000

United Hydrogen Global Inc. filed an amended registration statement (F-4/A) for a business combination involving a merger with Aimei Health Technology Co., Ltd. The transaction involves converting United Hydrogen's shares into Pubco's Class A and Class B Ordinary Shares, with a dual-class voting structure. The filing outlines the exchange ratio, share conversions, and the concentration of voting power under the new structure, emphasizing the significant control retained by Michael&Jason Limited, owned by founder Xia Ma.

F-4 filed

Gross proceeds $1,500,000,000

United Hydrogen Global Inc. is undergoing a business combination with Aimei Health Technology Co., Ltd., involving a merger structure where United Hydrogen will become a wholly owned subsidiary of Pubco. The transaction values United Hydrogen's shareholders' equity at $1.5 billion, paid entirely in newly issued Class A and Class B ordinary shares of Pubco. The deal includes a dual-class voting structure, with Class B shares granting ten votes per share compared to one for Class A, consolidating control under Xia Ma's entity, Michael&Jason Limited. The filing also outlines share conversions, redemption terms, and the impact on shareholder voting power post-merger.

DRS/A amended

United Hydrogen Global Inc. (Pubco) is undergoing a business combination with Aimei Health Technology Co., Ltd., involving mergers that will convert United Hydrogen's shares into Pubco's Class A and Class B Ordinary Shares. The transaction values United Hydrogen's shareholders' equity at $1.5 billion, with Pubco's Class B shares granting ten votes per share versus one for Class A, consolidating voting control under Xia Ma's entity. The filing outlines the conversion mechanics, share exchanges, and post-merger ownership structure, emphasizing the dual-class voting system and potential dilution for Aimei Health's public shareholders.

DRS/A amended

United Hydrogen Global Inc. (Pubco) is executing a business combination with Aimei Health Technology Co., Ltd., involving a $1.5 billion merger consideration paid entirely in newly issued Class A and Class B ordinary shares. The transaction will result in United Hydrogen becoming a wholly owned subsidiary of Pubco, with a dual-class voting structure granting Class B shares 10 votes per share versus 1 vote for Class A. The deal requires shareholder approvals and regulatory clearances, with potential dilution for Aimei Health shareholders if redemptions occur.

DRS/A amended

United Hydrogen Global Inc. filed a DRS/A amendment to its registration statement for a business combination involving a merger with Aimei Health Technology Co., Ltd. The transaction involves the exchange of United Hydrogen shares for Pubco (United Hydrogen Global Inc.) Class A and Class B Ordinary Shares, with a dual-class voting structure. The filing outlines the conversion of shares, voting rights, and the role of Michael&Jason Limited, owned by founder Xia Ma, in controlling voting power post-merger.

DRS filed

United Hydrogen Global Inc. filed a Form F-4 registration statement for a business combination with Aimei Health Technology Co., Ltd. through a reverse merger. The transaction involves merging United Hydrogen into Pubco, with shares converting into Pubco's Class A and Class B Ordinary Shares. The dual-class voting structure grants significant control to Xia Ma via Class B shares, while Aimei Health shareholders face dilution unless they redeem shares.